Camp4 Therapeutics (CAMP) Current Assets (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Current Assets data on file, last reported at $102.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 97.77% year-over-year to $102.2 million; the trailing twelve-month figure through Mar 2026 stood at $102.2 million (up 97.77% YoY), and the FY2025 full-year result was $114.1 million, up 71.87% from the prior year.
• Current Assets slipped to $102.2 million in Q1 2026, from $114.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $114.1 million in Q4 2025 to a low of $5.5 million in Q3 2024.
• A 4-year average of $62.3 million and a median of $59.0 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 65.9% in 2024 and jumped 1311.85% in 2025, its largest moves.
• Tracing CAMP's Current Assets over 4 years: stood at $40.0 million in 2023, then soared by 65.9% to $66.4 million in 2024, then soared by 71.87% to $114.1 million in 2025, then declined by 10.43% to $102.2 million in 2026.
• Business Quant data shows CAMP's Current Assets at $102.2 million in Q1 2026, $114.1 million in Q4 2025, and $77.7 million in Q3 2025.